These cells harbor EGFR-activating mutations as drivers, which correlate with a Fanconi anemia (FA)-like cellular phenotype reported to be a synthetic lethal factor for ATR inhibition (44,45). The gene discussed is ATR; the disease is Friedreich ataxia.